Company intelligence / Profile preview

Grayhawk Capital

Scottsdale, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Grayhawk Capital is a venture capital firm managing over $500 million across multiple funds, focusing on disruptive B2B SaaS, healthcare IT, and technology companies in the US Southwest and Israel. It does not itself conduct R&D or operate drug development or clinical trials.

Industry: Investors

Partnerships

Questa CapitalAmgen VenturesAZ Venture Development CorporationNova Prime

Beyond the preview

Go deeper on Grayhawk Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grayhawk Capital.

Explore the full profile